Tag Archives: company news

EMMIS COMMUNICATIONS (EMMS), profile, summary

Posted on by
Reply

Emmis Communications is a diversified media company engaged in radio broadcasting and magazine publishing operations. The company publishes various city and regional magazines including the Texas Monthly, LA Monthly and Indianapolis Monthly and several other regional magazines.

The company’s most valuable properties are the Radio Stations. Emmis (EMMS) owns and operates 21 FM and 2 AM radio stations in various parts of the country including big media markets like New York, Los Angeles, Chicago and Texas. It also owns and operates national radio networks in Slovakia and Bulgaria. Very Attractive, consolidation play, keep an eye!

Don’t miss the NEXT premium Alert!Sign-up, Get Alerts that MakeMoney!® we get compensated by the companies we feature. Always Read the full Disclosure/Disclaimer. Thanks

MNI, McClatchy,profile,summary

Posted on by
Reply

The McClatchy Group is one of the oldest Newspaper publishing companies in the United States. It owns The Miami Herald, The Sacramento Bee, the Fort Worth Star-Telegram and many other well known newspapers. It owns 30 daily newspapers and approximately 43 non-dailies in 29 markets.

McClatchy (MNI) also owns a portfolio of digital assets, including 14.4% of CareerBuilder.com, an online job site; and 33.3% of HomeFinder.com, as well as 25.6% of Classified Ventures LLC that offers classified Websites, such as the auto Website, Cars.com and Apartments.com.

Highly Undervalued – Medium to Long Term play – Its IP and Digital Assets are not getting the valuation they deserve. Keep an eye!

AVII, Avi Bio Pharma, Profile, Summary

Posted on by
Reply

AVI Bio Pharma is a leader in RNA based technology, the company is developing a range of potential therapeutic compounds that target different types of RNA. Unlike most other RNA-based approaches, AVI’s technology has been used to directly target both messenger RNA (mRNA) and precursor messenger RNA (pre-mRNA) to either down-regulate or up-regulate targeted genes or proteins.

This Bio-pharmaceutical company has several drugs in the pipeline, and strategic alliances with leading institutions and pharmaceutical firms. The company also has collaborative agreements with select academic, governmental and non-governmental organizations. Very Attractive, Medium to Long Term, Bouncing Back from 52WK Lows.

You are missing the Premium Alerts! Sign-up, Get Alerts that MakeMoney!® we get compensated by the companies we feature. Always Read the full Disclosure/Disclaimer. Thanks